Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter

M. Thompson, Ian; K. Pauler, Donna; J. Goodman, Phyllis; M. Tangen, Catherine; Scott Lucia, M.; L. Parnes, Howard; M. Minasian, Lori; G. Ford, Leslie; M. Lippman, Scott; David Crawford, E.; J. Crowley, John; A. Coltman, Charles

doi:10.1056/nejmoa031918

Public

Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter

Published in New England Journal of Medicine • May 26, 2004

Authors:

Ian M. Thompson

Donna K. Pauler

Phyllis J. Goodman

Abstract

BACKGROUND: The optimal upper limit of the normal range for prostate-specific antigen (PSA) is unknown. We investigated the prevalence of prostate cancer among men in the Prostate Cancer Prevention Trial who had a PSA level of 4.0 ng per milliliter or less. METHODS: Of 18,882 men enrolled in the pre...

Subject

Medicine

Liter

Rectal examination

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!